inosine pranobex
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
63
Go to page
1
2
3
July 28, 2026
Long-term survival (≥2 years) in subacute sclerosing panencephalitis: a systematic review of prolonged survivors.
(PubMed, Encephalitis)
- "Reported factors associated with improved survival included slower disease progression, older age at onset, earlier stage at diagnosis, and use of therapies such as inosine pranobex and interferon. SSPE survival outcomes show marked heterogeneity. Although prolonged survival occurs in some, most patients have poor outcomes, emphasizing the importance of early diagnosis and the need for effective therapies."
Journal • CNS Disorders • Infectious Disease • Measles
July 01, 2026
Beneficial immunomodulatory and hematological effects of bifidobacterium and lactobacillus probiotics in canine coronavirus vaccine induction in a murine model.
(PubMed, Open Vet J)
- "Twenty-four mice were randomly divided into the following four groups: control, CCoV induction, CCoV induction + isoprinosine, and CCoV induction + probiotics...The probiotic-treated group showed significant improvements in hematological parameters (leukocytes, hemoglobin, lymphocytes, and neutrophils) as well as reduced Casp-3 levels and increased IFN-γ expression compared with the other groups (p < 0.05).The T2 group exhibited reduced staining intensity in the mucosal and submucosal regions of the duodenum and alveolar structures of the lung, indicating the downregulation of apoptosis and inflammation compared with the C+ and T1 groups. Probiotic supplementation with Bifidobacterium and Lactobacillus demonstrated beneficial immunomodulatory and hematological effects in a murine CCoV vaccine model, supporting their potential role as adjuncts in CoV vaccination strategies."
Journal • Preclinical • Hematological Disorders • Infectious Disease • Inflammation • Novel Coronavirus Disease • CASP3 • IFNG
May 09, 2026
Beyond the complex: inosine drives the antiviral and epigenetic effects of inosine pranobex.
(PubMed, J Appl Genet)
- "While IP's immunomodulatory functions were not evaluated here, our findings strongly suggest that inosine contributes substantially to its antiviral efficacy. Further studies, including in vivo models, are warranted to clarify the epigenetic mechanism underlying these observations."
Journal
May 01, 2026
Ag-TiO2 photocatalyst for the degradation of isoprinosine: influence of silver modification on solar photocatalytic activity.
(PubMed, Environ Sci Pollut Res Int)
- "This unexpected result provides new mechanistic insight into how silver incorporation, phase composition, and catalyst pollutant interactions influence photocatalytic performance, highlighting that noble-metal doping is not universally beneficial. By establishing baseline activity under controlled conditions, these findings offer a benchmark for understanding pollutant-specific effects and guiding the rational design of photocatalysts for persistent antiviral contaminants."
Journal
April 27, 2026
The Anti-Vaccine Legacy: Re-Emergence of Subacute Sclerosing Panencephalitis in Children.
(PubMed, NeuroSci)
- "SSPE is a rare but serious, debilitating disease despite its complex, multidisciplinary care. Following a 10-year SSPE-free period, the reappearance of these pediatric cases constitutes a public health alert, unequivocally demonstrating the importance of measles vaccination."
Journal • CNS Disorders • Infectious Disease • Measles • Pediatrics
April 27, 2026
Re: Petersen E, Hviid AP. Inosine pranobex as a treatment of SARS-CoV-2? Int J Infect Dis. 2026.
(PubMed, Int J Infect Dis)
- No abstract available
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
March 06, 2026
Our Experience with Combination Therapy and it’s Outcomes in Pediatric Subacute Sclerosing Panencephalitis: A Retrospective Case Series
(AAN 2026)
- "All of them received monthly doses of intrathecal interferon alpha-2B (1.2 million IU), along with daily oral ribavirin (15 mg/kg), isoprinosine (50 mg/kg), and levamisole (2.5 mg/kg). Conclusions Combination therapy offered only transient benefit and failed to alter the trajectory of the disease. Our findings highlight the urgency of early diagnosis and reinforce the fact that measles vaccination is the only effective preventive strategy against SSPE."
Combination therapy • Retrospective data • CNS Disorders • Infectious Disease • Measles • Movement Disorders • Pediatrics • Pneumonia • Respiratory Diseases • Septic Shock
April 19, 2026
Posterior Segment Involvement in Subacute Sclerosing Panencephalitis: Clinical Features and Outcomes.
(PubMed, Ocul Immunol Inflamm)
- "Partial visual improvement was observed in one patient following treatment with levetiracetam, isoprinosine, and interferon beta-1a, whereas two patients showed neurological deterioration and died within four months and two years, respectively. Multimodal imaging, particularly OCT and FFA, provides valuable diagnostic insights. Early recognition of these ocular features may facilitate timely diagnosis and management of SSPE."
Journal • CNS Disorders • Genetic Disorders • Hematological Disorders • Macular Edema • Ocular Inflammation • Ophthalmology • Psychiatry • Retinal Disorders • Uveitis
April 04, 2026
Inosine pranobex as a treatment of SARS-CoV2?
(PubMed, Int J Infect Dis)
- No abstract available
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
April 02, 2026
Inosine pranobex was associated with a reduction in mortality in COVID-19 by over 22%, as reported in a retrospective study utilizing complete health data from the Czech national registry.
(PubMed, Int J Infect Dis)
- "IP administration in COVID-19 patients was associated with reduced mortality, supporting the need for further investigation of its therapeutic potential."
Journal • Retrospective data • Infectious Disease • Novel Coronavirus Disease
March 17, 2026
A dual-branch graph neural network architecture for drug-target binding affinity prediction.
(PubMed, Sci Rep)
- "We evaluated the proposed model against 45 state-of-the-art drug and target encoding baselines across well known Davis and KIBA datasets.The Proposed Model demonstrates a quantitative improvement over the GCN model, achieving a reduction in MSE (33.98 vs. 35.24), a slightly higher Pearson index (76.49 vs. 76.19), and a better Concordance index (85.41 vs. 84.41), indicating superior performance in terms of both prediction accuracy and ranking, demonstrating superior accuracy and robustness for candidate screening and establishing a new reference point for cheminformatics tasks. To illustrate practical impact, we performed a case study on COVID-19 drug repurposing: the top-ranked drugs have been also found potential drugs including Imunovir and Remdesivir from existing antiviral drugs."
Journal • Infectious Disease • Novel Coronavirus Disease
February 20, 2026
Investigation of the presence of cervical human papillomavirus and the distribution of preinvasive lesions in patients using immunomodulators-Inosine Pranobex.
(PubMed, Infect Agent Cancer)
- No abstract available
Journal • Cervical Cancer • Oncology
January 31, 2026
The last ten years with inosine pranobex - from an "old" therapeutic agent to vaccine research, including anti-cancer vaccines.
(PubMed, Cas Lek Cesk)
- "Renewed interest came only in the last decade, when IP began to reappear in connection with the treatment of acute respiratory infections, diseases caused by human papillomavirus (HPV), and other viral diseases, including COVID-19. It also began to be used as an adjuvant in the foot-and-mouth disease vaccine, and research began on an IP-based anti-tumor vaccine."
Journal • Review • Human Immunodeficiency Virus • Immunology • Infectious Disease • Novel Coronavirus Disease • Oncology • Respiratory Diseases
November 24, 2025
Clinical Experience with Inosine Pranobex in Pediatric Acute Respiratory Infections with Comorbidities: A Case Series from a Specialised Centre.
(PubMed, Pediatr Rep)
- " This case series highlights the common presence of cellular immune alterations in children with complex ARIs. While the observational nature of this study precludes any conclusions about causality, the favourable clinical course, safety profile, and strong immunological rationale support the need for prospective controlled trials to evaluate the role of IP in this specific high-risk paediatric population."
Journal • Immunology • Infectious Disease • Pediatrics • Pulmonary Disease • Respiratory Diseases • Tuberculosis
November 05, 2025
Experimental Treatment of Measles Encephalitis With Inosine Pranobex and Remdesivir in a Child With Lymphocytic Leukemia.
(PubMed, J Pediatr Hematol Oncol)
- "Although many agents have been studied in the treatment of Measles encephalitis with variable results, there are no effective strategies to mitigate the significant morbidity associated with measles encephalitis till date and treatment has remained largely supportive. In this report, a novel combination of antivirals have been shown to abrogate the morbid sequelae of Measles encephalitis with eventual complete recovery in a child with B-acute lymphoblastic leukemia."
Journal • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • CNS Disorders • Epilepsy • Hematological Malignancies • Infectious Disease • Leukemia • Measles • Oncology
July 23, 2025
Autoinoculation Treatment for Periungual Verrucae: Complete Clearance in Two Recalcitrant Cases
(EADV 2025)
- "He had been treated with cryotherapy for four sessions, topical keratolytics and inosine pranobex for a month, and lastly topical immunotherapy with squaric acid dibutyl ester for three months...She applied a topical solution containing salicylic acid with 5-fluorouracil to her lesion from time to time with no response...Povidone iodine was applied, and lidocaine was infiltrated to the area to be treated... The nail unit verruca represents the most frequently encountered tumor affecting the nail. Although the majority of the cases are self-limited, treatment-refractory lesions may have detrimental effects on the quality of life. A wide range of treatment options have been described in the literature, including both destructive and immunotherapeutic modalities."
Clinical • Infectious Disease
May 28, 2025
Subacute Sclerosing Panencephalitis: A Clinical, Radiological, and Outcome Study of 144 Cases.
(PubMed, Ann Indian Acad Neurol)
- "We found differences in the presentation of childhood- versus late-onset disease. Overall, the prognosis was not good, with increasing mortality observed with increasing duration of follow-up. Short-term outcomes were better. Future studies can look at the effect of immunomodulators on long-term outcomes in a larger sample size."
Journal • CNS Disorders • Epilepsy • Infectious Disease • Measles
May 25, 2025
SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) IN CHILDREN: A CASE SERIES
(ESPID 2025)
- "Recognition of this syndrome is critical, necessitating prompt EEG and measles antibody testing for accurate diagnosis. Early isoprinosine intervention is essential."
Clinical • Infectious Disease • Measles
April 16, 2025
Subacute Sclerosing Panencephalitis: Recent Advances in Pathogenesis, Diagnosis, and Treatment.
(PubMed, Ann Indian Acad Neurol)
- "Treatment remains challenging, with isoprinosine, interferon-α, ribavirin, and newer agents like favipiravir and aprepitant offering new hope. The coronavirus disease 2019 pandemic's adverse impact on measles vaccination rates highlights the urgent need for robust measles immunization campaigns. Future directions involve exploring antiviral fusion peptide inhibitors and artificial intelligence-driven diagnostic tools to improve early detection, treatment efficacy, and outcome prediction in SSPE."
Journal • CNS Disorders • Epilepsy • Infectious Disease • Inflammation • Measles • Movement Disorders • Novel Coronavirus Disease • Palliative care • Respiratory Diseases
December 29, 2024
Issues of treatment and prevention of recurrent inflammatory diseases of the upper respiratory tract: An immunologist's view. A review
(PubMed, Ter Arkh)
- "The immunomodulator inosine pranobex, due to its unique combined (immunotropic and antiviral) properties, demonstrates effectiveness in the complex treatment of viral respiratory infections, including in combination with herpes viruses, and is successfully used to prevent frequent relapses of infectious and inflammatory diseases of the URT. The domestic analogue of inosine pranobex Normomed® [JSC "Valenta Pharm"», ЛП-№(002470)-(РГ-RU), ЛП-№(005542)-(РГ-RU)], has a good safety and bioequivalence profile, and occupies a worthy field in the Russian pharmaceutical market among drugs recommended for the treatment of viral infections in adults and children."
Journal • Review • Infectious Disease • Inflammation • Respiratory Diseases
December 06, 2024
Contemporary Treatment Practices for Subacute Sclerosing Panencephalitis: A Nationwide Survey Among Adult and Pediatric Neurologists in India.
(PubMed, Ann Indian Acad Neurol)
- "While SSPE remains a vaccine-preventable illness and the focus should be on prevention through vaccination, there is an unmet urgent need among Indian neurologists for better-defined treatment strategies for patients with SSPE."
Journal • CNS Disorders • Infectious Disease • Measles • Movement Disorders • Pediatrics
October 10, 2024
The Rare Case Presentation of Adult-Onset Fulminant Subacute Sclerosing Panencephalitis in a 24-Year-Old Male.
(PubMed, Cureus)
- "Despite the absence of a definitive cure for this disorder, a regimen combining intrathecal interferon-α (IFN-α) and daily oral isoprinosine has demonstrated effectiveness...He exhibited progressive weakness, frequent postural instability, and recurrent generalized tonic-clonic seizures. Increased measles antibody concentrations in the cerebrospinal fluid (CSF), prominent amplitude spikes on the electroencephalogram (EEG), and heightened fluid-attenuated inversion recovery (FLAIR) signals on brain magnetic resonance imaging (MRI) suggested a diagnosis of SSPE."
Journal • CNS Disorders • Epilepsy • Infectious Disease • Measles • IFNA1
August 06, 2024
Changes of cellular immunological parameters in patients with psoriasis and activated chronic herpes simplex virus infection during treatment
(EADV 2024)
- "The phenotyping of lymphocytes in patients with psoriasis and activated HSV 1,2 was characterized by an increase of NK cells (CD16+56+, CD45+; p=0.0151) , cytotoxic T-lymphocytes (CD3+CD8+, CD45+; p= 0.0019) , T-helper (CD3+CD4 +, CD45+; p=0.0011) and decreasing activity of their regulatory subpopulation (CD4+, CD25+; p=0.0528) compared to patients with psoriasis. In patients with psoriasis and activated HSV 1,2, the multifactorial relationship between the number of CD19+, CD45+-lymphocytes, CD3+CD8+, CD45+- lymphocytes, and CD3+HLA+-lymphocytes has been detected. The antiviral treatment on the background of basic therapy caused a decrease in the number of T-helpers (p=0.0518) , increased activity of T-lymphocytes (p=0.0251) and regulatory cells (p=0.0365) in mild HSV 1,2 using inosine pranobex in patients with psoriasis, and a decrease of NK-cells (p=0.0412) and increasing activity of regulatory lymphocytes (p=0.0351) in moderate and severe HSV 1,2 in patients with..."
Clinical • Dermatology • Herpes Simplex • Immunology • Infectious Disease • Psoriasis • CD8 • IL2RA • ISG20 • PTPRC
July 29, 2024
A Rare Case of Subacute Sclerosing Panencephalitis in an Immunized Patient.
(PubMed, Cureus)
- "Treatment included isoprinosine, lamivudine, and intrathecal interferon-alpha for symptom management and disease progression...The patient showed partial improvement post-treatment and was discharged for follow-up. By reporting this case, we would like to emphasize clinical judgment, early detection of the symptoms, and lateral thinking to diagnose fatal conditions such as post-measles SSPE, even in fully immunized patients."
Journal • CNS Disorders • Infectious Disease • Inflammation • Measles
April 09, 2024
An examination of the effectiveness of the expired drug isoprinosine in preventing aluminum corrosion in alkaline solutions using both computational and experimental techniques.
(PubMed, RSC Adv)
- "Furthermore, molecular dynamic was simulated to explore the corrosion inhibition efficiency and mechanism of inhibition. The computational results are in the same agreement with experimental results, showing that isoprinosine can inhibit the corrosion of aluminum in 0.5 M NaOH."
Journal
1 to 25
Of
63
Go to page
1
2
3